Vimarsana
Biggest News Aggregation in the World

Restated Listing Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Restated Listing Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Restated Listing Statement Today - Breaking & Trending Today

Braxia Scientific Reports Q3 2024 Financial Results - Vimarsana News

Braxia Scientific Reports Q3 2024 Financial Results

Braxia Scientific Corp. , , a medical research company with clinics providing innovative ketamine and psilocybin treatments for depression and related disorders, today announced the filing of its...

Braxia Scientific Reports Q2 2024 Financial Results and Provides Corporate Update - Vimarsana News

Braxia Scientific Reports Q2 2024 Financial Results and Provides Corporate Update

Braxia Scientific Corp.   , a medical research company with clinics providing innovative ketamine and psilocybin treatments for depression and related disorders, today announced the filing of its...

Telemedicine Stock News: Braxia Scientific (CSE: BRAX) Reports Q1 Fiscal 2024 Financial Results - Vimarsana News

Telemedicine Stock News: Braxia Scientific (CSE: BRAX) Reports Q1 Fiscal 2024 Financial Results

Telemedicine Stock News: Braxia Scientific (CSE: BRAX) Reports Q1 Fiscal 2024 Financial Results

Braxia Scientific Corp.: Braxia Scientific Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic - Vimarsana News

Braxia Scientific Corp.: Braxia Scientific Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic

Company Taking Strategic Actions to Prioritize Clinic Expansion, Enhance Operational Effectiveness and Right Size Cost Structure Toronto, Ontario--(Newsfile Corp. - June 9, 2023) - Braxia Scientific Corp.

Braxia Scientific Corp.: Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine and Psychedelics Clinical IP - Vimarsana News

Braxia Scientific Corp.: Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine and Psychedelics Clinical IP

Toronto, Ontario--(Newsfile Corp. - March 16, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC PINK: BRAXF) (FWB: 4960) ("Braxia", or the "Company"), a medical research and telemedicine company with clinics